EDIT · Editas Medicine, Inc. · Investor Relations
$1.70
-0.01 (-0.58%)
At close · Nov 20
Return incl. dividend (before tax)
Q2 2024 earnings call transcript
Market Cap
$263.92M
Shares
154.34M
Volume · Nov 19
1.93M
Avg daily vol (3M)
2.65M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-04 | 2026 Jefferies Global Healthcare Conference | Conference |
| 2026-03-12 | Barclays 28th Annual Global Healthcare Conference | Conference |
| 2026-03-02 | TD Cowen 46th Annual Health Care Conference | Conference |
| 2025-12-02 | 8th Annual Evercore Healthcare Conference | Conference |
| 2025-10-21 | Chardan 9th Annual Genetic Medicines Conference | Conference |
| 2025-10-14 | H.C. Wainwright Genetic Medicines Virtual Conference | Conference |
| 2025-09-04 | Cantor Global Healthcare Conference | Conference |
| 2025-09-02 | Editas Medicine Lead In Vivo Development Candidate Webinar | Event |
| 2025-05-13 | Bank of America Global Healthcare Conference | Conference |
| 2025-03-11 | Barclays 27th Annual Global Healthcare Conference | Conference |
Key facts
CIK
1650664
CUSIP
28106W103
13F (30d)
243 filings
207 filers
Visit website
Investor relations